Researchers, executives, and thought leaders across healthcare gathered at NVIDIA GTC to discuss today’s pressing AI life science applications.

Under the partnership, the Secaucus-based company becomes the first national laboratory to implement these services across a range of areas.

Quest Diagnostics logged a -1.0% change during today's afternoon session, and is now trading at a price of $166.27 per share.

Public health labs have handled most testing thus far for the Texas and New Mexico outbreaks, but commercial labs are beginning to bring molecular measles assays online.

GE Healthcare, Synchron and robotics companies were among the medtech firms that used Nvidia’s GTC 2025 conference to share ...